283 TRAMADOL, DIHYDROCODEINE AND METABOLITES LEVELS IN CANCER PATIENTS TREATED WITH CONTROLLED RELEASE DIHYDROCODEINE AND TRAMADOL

MLA

Michał Szulc, et al. “283 Tramadol, Dihydrocodeine and Metabolites Levels in Cancer Patients Treated with Controlled Release Dihydrocodeine and Tramadol.” European Journal of Pain, vol. 13, Sept. 2009. EBSCOhost, https://doi.org/10.1016/s1090-3801(09)60286-x.

APA

Michał Szulc, Przemysław Ł. Mikołajczak, Wojciech Leppert, & Ewa Kamińska. (2009). 283 Tramadol, Dihydrocodeine and Metabolites Levels in Cancer Patients Treated with Controlled Release Dihydrocodeine and Tramadol. European Journal of Pain, 13. https://doi.org/10.1016/s1090-3801(09)60286-x

Chicago

Michał Szulc, Przemysław Ł. Mikołajczak, Wojciech Leppert, and Ewa Kamińska. 2009. “283 Tramadol, Dihydrocodeine and Metabolites Levels in Cancer Patients Treated with Controlled Release Dihydrocodeine and Tramadol.” European Journal of Pain 13 (September). doi:10.1016/s1090-3801(09)60286-x.